Inflammatory muscle disease: clinical presentation and assessment of patients.
Muscle weakness and muscle fatigue are the most common manifestations in patients with idiopathic inflammatory myopathies (ie, myositis), but other organs are frequently involved such as skin, lungs, joints, and the heart. These could occur before, simultaneously with, or after the onset of muscle symptoms. One tool to structure outcome measure is the International Classification of Functioning, Disability, and Health. Measures of "disability" can be divided into impairment and activity limitation/participation restriction. Most of the available outcome measures for myositis could be classified as measures of impairment, such as muscle strength, serum levels of muscle enzymes, and pulmonary function tests. Measures of activity limitation/participation restriction are also important, such as the myositis activities profile, the visual analog scale to assess impact on general well-being, and the generic short form-36 to capture impact on health-related quality of life.
Alexanderson
Helene
H
Department of Physical Therapy, Rheumatology Unit D2:07, Karolinska University Hospital, Solna SE-171 76, Stockholm, Sweden. helene.alexandersson@karolinska.se
Lundberg
Ingrid E
IE
D006233:Persons with Disabilities / Q000145:classification*; D006801:Humans; D018763:Muscle Fatigue; D018908:Muscle Weakness / Q000209:etiology; D009220:Myositis / Q000150:complications / Q000175:diagnosis* / Q000276:immunology; D018434:Sickness Impact Profile
Radiology. 2006 Feb;238(2):640-9
16371585
J Rheumatol. 1996 Aug;23(8):1380-4
8856617
J Am Acad Dermatol. 2006 Apr;54(4):597-613
16546580
Arthritis Rheum. 2002 Feb;46(2):467-74
11840450
N Engl J Med. 1991 Nov 21;325(21):1487-98
1658649
Ann Intern Med. 1995 May 1;122(9):715-24
7702234
Arthritis Rheum. 1994 May;37(5):736-46
8185702
Rheumatology (Oxford). 2001 Nov;40(11):1262-73
11709610
Ann Rheum Dis. 2002 Jan;61(1):37-41
11779756
Ann Rheum Dis. 2006 Feb;65(2):242-5
16410528
Eur Neurol. 2003;50(1):10-5
12824706
J Rehabil Med. 2003 Jan;35(1):31-5
12610846
Clin Rehabil. 2003 Feb;17(1):83-7
12617382
Br J Rheumatol. 1998 Dec;37(12):1338-42
9973161
J Rheumatol. 2001 May;28(5):1106-11
11361197
Arthritis Rheum. 1997 Nov;40(11):1976-83
9365086
Med Care. 1992 Jun;30(6):473-83
1593914
Arthritis Rheum. 2006 Nov;54(11):3682-9
17075819
Ann Rheum Dis. 2001 Feb;60(2):116-23
11156543
Ann Neurol. 2002 Mar;51(3):369-72
11891832
Rheumatology (Oxford). 2006 Oct;45 Suppl 4:iv18-21
16980718
Rheumatology (Oxford). 2004 Jan;43(1):49-54
12867580
Scand J Rheumatol. 2000;29(2):95-102
10777122
Scand J Rheumatol. 2006 May-Jun;35(3):229-32
16766371
Ann Rheum Dis. 2006 Feb;65(2):249-52
16410529
Arthritis Rheum. 1980 Feb;23(2):137-45
7362664
J Rheumatol. 2002 Apr;29(4):861-2
11950039
J Neurol. 2006 Dec;253(12 ):1625-32
17219033
Ann Rheum Dis. 2004 Mar;63(3):297-301
14962966
Medicine (Baltimore). 1991 Nov;70(6):360-74
1659647
Scand J Rheumatol. 2000;29(5):295-301
11093595
Rheumatology (Oxford). 2007 May;46(5):842-5
17255133
Muscle Nerve. 1997 Oct;20(10):1242-8
9324080
Br J Rheumatol. 1998 Feb;37(2):196-200
9569076
Rheum Dis Clin North Am. 2002 Nov;28(4):935-77
12506779
Arthritis Rheum. 2006 Feb 15;55(1):114-22
16463422
J Rheumatol. 2000 Dec;27(12):2801-9
11128667
Eur Respir J. 2006 Nov;28(5):1005-12
16837503
Rheumatology (Oxford). 2006 Jul;45(7):874-9
16449366
Ann Neurol. 1984 Aug;16(2):193-208
6383191
J Rheumatol. 2002 Nov;29(11):2386-92
12415597
J Rheumatol. 1993 Jan;20(1):21-7
8441160
Ann Rheum Dis. 2006 Dec;65(12):1635-8
16679430
Rheumatology (Oxford). 2002 Jan;41(1):22-6
11792875